From November 23 to 25, the 19th China Pharmaceutical Growth Conference themed "Intelligent Chain Deepening, All-Round Innovation" was grandly held at the International Convention and Exhibition Center of Lishui Economic Development Zone, a scenic location. As an annual ideological feast and achievement review of the pharmaceutical industry, it gathered over 6,000 guests including academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering, economists, national medical masters, national senior TCM physicians, authoritative experts from pharmaceutical colleges and research institutions, industry leaders and media representatives, to jointly explore the path of collaborative innovation and high-quality development of the entire pharmaceutical industry chain.

As a local pharmaceutical enterprise, Zhejiang Benefit Pharmaceutical Co., Ltd. was invited to participate in the exhibition (Booth No.: L006). On this high-standard and high-level exchange platform, the company comprehensively demonstrated its innovative achievements and core strengths, and explored the future trends of the industry with colleagues from all walks of life.
Cordial Care from Leaders, Encouraging Messages for Future Progress

During the exhibition, leaders including Ma Peihua, Vice Chairman of the 12th National Committee of the Chinese People's Political Consultative Conference, and Wu Shunze, Secretary of the Lishui Municipal Party Committee, specially stopped at the booth of Zhejiang Benefit Pharmaceutical Co., Ltd. during their tour of the exhibition hall to learn about the company's development in detail. The leaders showed great interest in Tetrastigma hemsleyanum, a genuine medicinal herb of Lishui that the company has been focusing on, and paid close attention to the company's newly launched health product – Hericium and Pericarpium Citri Reticulatae Decoction. After listening to the report, the leaders fully affirmed the breakthroughs and progress made by Zhejiang Benefit Pharmaceutical Co., Ltd. in the field of pharmaceutical R&D, and encouraged the company to continue adhering to innovation-driven development, deepen its presence in professional fields, and contribute more to the development of Lishui's grand health industry. The cordial care and earnest expectations from municipal leaders have greatly inspired all staff of Zhejiang Benefit Pharmaceutical Co., Ltd. and injected strong impetus into the company's future development!
Focus on Exhibition Site, Showcase Innovative Charm




At this conference, the booth of Zhejiang Benefit Pharmaceutical Co., Ltd. attracted the attention of numerous guests and partners. Through various forms such as product displays, graphic explanations and professional consultations, the company focused on presenting its latest achievements in TCM modernization, classic prescription development and health product innovation. In particular, the product system centered on Tetrastigma hemsleyanum and Hericium and Pericarpium Citri Reticulatae Decoction integrating the concept of medicine-food homology have won unanimous praise and enthusiastic inquiries from the audience on site due to their distinctive features and clear health benefits, becoming a highlight of the exhibition area.
Thousands of Runners Unite, Highlighting the Vibrant Vitality of the Industry

On the morning of November 24, the "Run, Health Guardians" thousand-person running event organized by the China Pharmaceutical Materials Association kicked off dynamically. A team of 100 "Benefit Partners" sent by Zhejiang Benefit Pharmaceutical Co., Ltd. participated in the event in high spirits, showing the positive spirit of pharmaceutical practitioners and their firm belief in safeguarding public health through running.
Stay True to Original Aspiration for Common Progress, Forge Ahead to Write a New Chapter

Through this participation, Zhejiang Benefit Pharmaceutical Co., Ltd. not only effectively enhanced its brand awareness and industry influence, but also established initial contact with many potential partners, laying a solid foundation for subsequent market expansion and in-depth cooperation. We deeply felt the vigorous development vitality and unlimited potential of China's pharmaceutical industry, and further strengthened our corporate mission of "Devoting to Human Health, Providing High-Quality Pharmaceuticals".







